<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39407733</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Retinal Microvasculature Changes Linked to Executive Function Impairment after COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5671</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13195671</ELocationID><Abstract><AbstractText><b>Background/Objectives</b>: Studies using optical coherence tomography angiography (OCTA) have revealed that individuals recovering from COVID-19 have a reduced retinal vascular density (VD) and larger foveal avascular zones (FAZs) than healthy individuals, with more severe cases showing greater reductions. We aimed to examine aspects of the retinal microvascularization in patients with post-COVID-19 condition (PCC) classified by COVID-19 severity and how these aspects relate to cognitive performance. <b>Methods</b>: This observational cross-sectional study included 104 PCC participants from the NAUTILUS Project, divided into severe (n = 59) and mild (n = 45) COVID-19 groups. Participants underwent cognitive assessments and OCTA to measure VD and perfusion density (PD) in the superficial capillary plexus (SVP) and FAZ. Analysis of covariance and partial Pearson and Spearman correlations were used to study intergroup differences and the relationships between cognitive and OCTA variables. <b>Results</b>: Severe PCC participants had significantly lower central (<i>p</i> = 0.03) and total (<i>p</i> = 0.03) VD, lower central (<i>p</i> = 0.02) PD measurements, and larger FAZ areas (<i>p</i> = 0.02) and perimeters (<i>p</i> = 0.02) than mild cases. Severe cases showed more cognitive impairment, particularly in speed processing (<i>p</i> = 0.003) and executive functions (<i>p</i> = 0.03). Lower central VD, lower central PD, and larger FAZ areas and perimeters were associated with worse executive function performance in the entire PCC sample and in the mild COVID-19 group. <b>Conclusions</b>: Retinal microvascular alterations, characterized by reduced VD and PD in the SVP and larger FAZ areas, were associated with cognitive impairments in PCC individuals. These findings suggest that severe COVID-19 leads to long-lasting microvascular damage, impacting retinal and cognitive health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ariza</LastName><ForeName>Mar</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1020-6945</Identifier><AffiliationInfo><Affiliation>Grup de Recerca en Cervell, Cognició i Conducta, Consorci Sanitari de Terrassa (CST)-Hospital Universitari, 08227 Terrassa, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unitat de Psicologia Mèdica, Departament de Medicina, Universitat de Barcelona (UB), 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delas</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Ophtalmology Department, Consorci Sanitari de Terrassa (CST)-Hospital Universitari, 08227 Terrassa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Ophtalmology Department, Consorci Sanitari de Terrassa (CST)-Hospital Universitari, 08227 Terrassa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Frutos</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Ophtalmology Department, Consorci Sanitari de Terrassa (CST)-Hospital Universitari, 08227 Terrassa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cano</LastName><ForeName>Neus</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7760-3692</Identifier><AffiliationInfo><Affiliation>Grup de Recerca en Cervell, Cognició i Conducta, Consorci Sanitari de Terrassa (CST)-Hospital Universitari, 08227 Terrassa, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departament de Ciències Bàsiques, Universitat Internacional de Catalunya, 08195 Sant Cugat del Vallès, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segura</LastName><ForeName>Bàrbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Unitat de Psicologia Mèdica, Departament de Medicina, Universitat de Barcelona (UB), 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Neurociències, Universitat de Barcelona (UB), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrué</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3342-1085</Identifier><AffiliationInfo><Affiliation>Departament de Ciències de la Computació, Universitat Politècnica de Catalunya-BarcelonaTech, 08034 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bejar</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5281-3888</Identifier><AffiliationInfo><Affiliation>Departament de Ciències de la Computació, Universitat Politècnica de Catalunya-BarcelonaTech, 08034 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asaad</LastName><ForeName>Mouafk</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ophtalmology Department, Consorci Sanitari de Terrassa (CST)-Hospital Universitari, 08227 Terrassa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortés</LastName><ForeName>Claudio Ulises</ForeName><Initials>CU</Initials><AffiliationInfo><Affiliation>Departament de Ciències de la Computació, Universitat Politècnica de Catalunya-BarcelonaTech, 08034 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Junqué</LastName><ForeName>Carme</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6381-3063</Identifier><AffiliationInfo><Affiliation>Unitat de Psicologia Mèdica, Departament de Medicina, Universitat de Barcelona (UB), 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Neurociències, Universitat de Barcelona (UB), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garolera</LastName><ForeName>Maite</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7443-8249</Identifier><AffiliationInfo><Affiliation>Grup de Recerca en Cervell, Cognició i Conducta, Consorci Sanitari de Terrassa (CST)-Hospital Universitari, 08227 Terrassa, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departament de Ciències Bàsiques, Universitat Internacional de Catalunya, 08195 Sant Cugat del Vallès, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuropsychology Unit, Consorci Sanitari de Terrassa (CST)-Hospital Universitari, 08227 Terrassa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nautilus Project Collaborative Group</LastName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>202111-30-31-32</GrantID><Agency>Fundacio La Marató de TV3</Agency><Country /></Grant><Grant><GrantID>TED2021-130409B-C51</GrantID><Agency>Ministerio de Ciencia e Innovación. Fondos Next Generation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">executive function</Keyword><Keyword MajorTopicYN="N">optical coherence tomography angiography</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">retina</Keyword><Keyword MajorTopicYN="N">superficial capillary plexus</Keyword><Keyword MajorTopicYN="N">vessel density</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39407733</ArticleId><ArticleId IdType="pmc">PMC11477391</ArticleId><ArticleId IdType="doi">10.3390/jcm13195671</ArticleId><ArticleId IdType="pii">jcm13195671</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. Lancet Infect. Dis. 2022;22:e102–e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC . Prevalence of Post COVID-19 Condition Symptoms: A Systematic Review and Meta-Analysis of Cohort Study Data, Stratified by Recruitment Setting. Europe Centre For Disease Prevention and Control; Solna, Sweden: 2022.</Citation></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., olde Hartman T.C., Rosmalen J.G.M. Persistence of Somatic Symptoms after COVID-19 in the Netherlands: An Observational Cohort Study. Lancet. 2022;400:452–461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan M., Wang X., Gong M., Wang Q., Li Y., Jia J. Post-COVID Cognitive Dysfunction: Current Status and Research Recommendations for High Risk Population. Lancet Reg. Health West. Pac. 2023;38:100836. doi: 10.1016/j.lanwpc.2023.100836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2023.100836</ArticleId><ArticleId IdType="pmc">PMC10344681</ArticleId><ArticleId IdType="pubmed">37457901</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias-Guiu J.A., Herrera E., González-Nosti M., Krishnan K., Delgado-Alonso C., Díez-Cirarda M., Yus M., Martínez-Petit Á., Pagán J., Matías-Guiu J., et al. Development of Criteria for Cognitive Dysfunction in Post-COVID Syndrome: The IC-CoDi-COVID Approach. Psychiatry Res. 2023;319:115006. doi: 10.1016/j.psychres.2022.115006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.115006</ArticleId><ArticleId IdType="pubmed">36521337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M., Cano N., Segura B., Adan A., Bargalló N., Caldú X., Campabadal A., Sala-llonch R., Barrué C., Bejar J., et al. Neuropsychological Impairment in Post-COVID Condition Individuals with and without Cognitive Complaints. Front. Aging Neurosci. 2022;14:1029842. doi: 10.3389/fnagi.2022.1029842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1029842</ArticleId><ArticleId IdType="pmc">PMC9631485</ArticleId><ArticleId IdType="pubmed">36337708</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Long COVID Syndrome-Associated Brain Fog. J. Med. Virol. 2022;94:979–984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Pedersen J.K., Gunnarsson D.V., Roikjer T.K., Podlekareva D., Hansen H., Dall C.H., Johnsen S. Cognitive Impairments among Patients in a Long-COVID Clinic: Prevalence, Pattern and Relation to Illness Severity, Work Function and Quality of Life. J. Affect. Disord. 2023;324:162–169. doi: 10.1016/j.jad.2022.12.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.12.122</ArticleId><ArticleId IdType="pmc">PMC9795797</ArticleId><ArticleId IdType="pubmed">36586593</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M., Cano N., Segura B., Adan A., Bargalló N., Caldú X., Campabadal A., Jurado M.A., Mataró M., Pueyo R., et al. COVID-19 Severity Is Related to Poor Executive Function in People with Post-COVID Conditions. J. Neurol. 2023;270:2392–2408. doi: 10.1007/s00415-023-11587-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-11587-4</ArticleId><ArticleId IdType="pmc">PMC10026205</ArticleId><ArticleId IdType="pubmed">36939932</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group Clinical Characteristics with Inflammation Profiling of Long COVID and Association with 1-Year Recovery Following Hospitalisation in the UK: A Prospective Observational Study. Lancet Respir. Med. 2022;10:761–775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M., Béjar J., Barrué C., Cano N., Segura B., NAUTILUS Project Collaborative Group. Cortés C.U., Junqué C., Garolera M. Cognitive Reserve, Depressive Symptoms, Obesity, and Change in Employment Status Predict Mental Processing Speed and Executive Function after COVID-19. Eur. Arch. Psychiatry Clin. Neurosci. 2024 doi: 10.1007/s00406-023-01748-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-023-01748-x</ArticleId><ArticleId IdType="pubmed">38285245</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A.C.S., Tan G.S., Denniston A.K., Keane P.A., Ang M., Milea D., Chakravarthy U., Cheung C.M.G. An Overview of the Clinical Applications of Optical Coherence Tomography Angiography. Eye. 2018;32:262–286. doi: 10.1038/eye.2017.181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/eye.2017.181</ArticleId><ArticleId IdType="pmc">PMC5811700</ArticleId><ArticleId IdType="pubmed">28885606</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell J.P., Zhang M., Hwang T.S., Bailey S.T., Wilson D.J., Jia Y., Huang D. Detailed Vascular Anatomy of the Human Retina by Projection-Resolved Optical Coherence Tomography Angiography. Sci. Rep. 2017;7:42201. doi: 10.1038/srep42201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42201</ArticleId><ArticleId IdType="pmc">PMC5301488</ArticleId><ArticleId IdType="pubmed">28186181</ArticleId></ArticleIdList></Reference><Reference><Citation>Nageeb Louz R.E., Salah Eddin M.A., Macky T.A., Tolba D.A.A. Post COVID-19 Retinal Evaluation Using Optical Coherence Tomography Angiography: A Case Control Study. Ocul. Immunol. Inflamm. 2023;31:1175–1183. doi: 10.1080/09273948.2022.2141651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2022.2141651</ArticleId><ArticleId IdType="pubmed">36413337</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Zamora J., Bilbao-Malavé V., Gándara E., Casablanca-Piñera A., Boquera-Ventosa C., Landecho M.F., Zarranz-Ventura J., García-Layana A. Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia Assessed by Optical Coherence Tomography Angiography. Biomedicines. 2021;9:247. doi: 10.3390/biomedicines9030247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9030247</ArticleId><ArticleId IdType="pmc">PMC7998142</ArticleId><ArticleId IdType="pubmed">33801324</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosmo E., Frizziero L., Schiavon S., Cattelan A.M., Leoni D., Capizzi A., Torresin T. The Neurovascular Retinal Involvement in a Large Population of Patients Recovered from COVID-19: An OCT and OCT Angiography Study. Eye. 2024;38:1674–1680. doi: 10.1038/s41433-024-02991-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41433-024-02991-9</ArticleId><ArticleId IdType="pmc">PMC11156865</ArticleId><ArticleId IdType="pubmed">38402287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilbao-Malavé V., González-Zamora J., De Viteri M.S., De La Puente M., Gándara E., Casablanca-Piñera A., Boquera-Ventosa C., Zarranz-Ventura J., Landecho M.F., García-Layana A. Persistent Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia at 6-Months Follow-up Assessed by Optical Coherence Tomography Angiography. Biomedicines. 2021;9:502. doi: 10.3390/biomedicines9050502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9050502</ArticleId><ArticleId IdType="pmc">PMC8147391</ArticleId><ArticleId IdType="pubmed">34063291</ArticleId></ArticleIdList></Reference><Reference><Citation>Turker I.C., Dogan C.U., Dirim A.B., Guven D., Kutucu O.K. Evaluation of Early and Late COVID-19-Induced Vascular Changes with OCTA. Can. J. Ophthalmol. 2022;57:236–241. doi: 10.1016/j.jcjo.2021.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjo.2021.05.001</ArticleId><ArticleId IdType="pmc">PMC8139253</ArticleId><ArticleId IdType="pubmed">34118187</ArticleId></ArticleIdList></Reference><Reference><Citation>Kal M., Winiarczyk M., Zarębska-Michaluk D., Odrobina D., Cieśla E., Płatkowska-Adamska B., Biskup M., Pabjan P., Głuszek S., Mackiewicz J. Long-Term Effect of SARS-CoV-2 Infection on the Retinal and Choroidal Microvasculature. J. Clin. Med. 2023;12:2528. doi: 10.3390/jcm12072528.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12072528</ArticleId><ArticleId IdType="pmc">PMC10095143</ArticleId><ArticleId IdType="pubmed">37048610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata M.Á., García S.B., Sánchez-Moltalvá A., Falcó A., Otero-Romero S., Arcos G., Velazquez-Villoria D., García-Arumí J. Retinal Microvascular Abnormalities in Patients after COVID-19 Depending on Disease Severity. Br. J. Ophthalmol. 2022;106:559–563. doi: 10.1136/bjophthalmol-2020-317953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2020-317953</ArticleId><ArticleId IdType="pubmed">33328184</ArticleId></ArticleIdList></Reference><Reference><Citation>Banderas García S., Aragón D., Azarfane B., Trejo F., Garrell-Salat X., Sánchez-Montalvá A., Otero-Romero S., Garcia-Arumi J., Zapata M.A. Persistent Reduction of Retinal Microvascular Vessel Density in Patients with Moderate and Severe COVID-19 Disease. BMJ Open Ophthalmol. 2022;7:e000867. doi: 10.1136/bmjophth-2021-000867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjophth-2021-000867</ArticleId><ArticleId IdType="pmc">PMC8753095</ArticleId><ArticleId IdType="pubmed">35039796</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Ganslmayer M., Lucio M., Kruse F., Hoffmanns J., Moritz M., Rogge L., Heltmann F., Szewczykowski C., Fürst J., et al. Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front. Med. 2021;8:676554. doi: 10.3389/fmed.2021.676554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.676554</ArticleId><ArticleId IdType="pmc">PMC8299003</ArticleId><ArticleId IdType="pubmed">34307408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaw F.G.P., Warter A., Cavichini M., Knight D., Li A., Deussen D., Galang C., Heinke A., Mendoza V., Borooah S., et al. Retinal Tissue and Microvasculature Loss in COVID-19 Infection. Sci. Rep. 2023;13:5100. doi: 10.1038/s41598-023-31835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-31835-x</ArticleId><ArticleId IdType="pmc">PMC10050819</ArticleId><ArticleId IdType="pubmed">36991025</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor M., McGrath O., Drira I., Aslam T. Retinal Microvasculature Image Analysis Using Optical Coherence Tomography Angiography in Patients with Post-COVID-19 Syndrome. J. Imaging. 2023;9:234. doi: 10.3390/jimaging9110234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jimaging9110234</ArticleId><ArticleId IdType="pmc">PMC10672226</ArticleId><ArticleId IdType="pubmed">37998081</ArticleId></ArticleIdList></Reference><Reference><Citation>London A., Benhar I., Schwartz M. The Retina as a Window to the Brain-From Eye Research to CNS Disorders. Nat. Rev. Neurol. 2013;9:44–53. doi: 10.1038/nrneurol.2012.227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.227</ArticleId><ArticleId IdType="pubmed">23165340</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton N., Aslam T., MacGillivray T., Pattie A., Deary I.J., Dhillon B. Retinal Vascular Image Analysis as a Potential Screening Tool for Cerebrovascular Disease: A Rationale Based on Homology between Cerebral and Retinal Microvasculatures. J. Anat. 2005;206:319–348. doi: 10.1111/j.1469-7580.2005.00395.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7580.2005.00395.x</ArticleId><ArticleId IdType="pmc">PMC1571489</ArticleId><ArticleId IdType="pubmed">15817102</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumitrascu O.M., Demaerschalk B.M., Valencia Sanchez C., Almader-Douglas D., O’Carroll C.B., Aguilar M.I., Lyden P.D., Kumar G. Retinal Microvascular Abnormalities as Surrogate Markers of Cerebrovascular Ischemic Disease: A Meta-Analysis. J. Stroke Cerebrovasc. Dis. 2018;27:1960–1968. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2018.02.041</ArticleId><ArticleId IdType="pubmed">29571764</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikram M.K., De Jong F.J., Van Dijk E.J., Prins N.D., Hofman A., Breteler M.M.B., De Jong P.T.V.M. Retinal Vessel Diameters and Cerebral Small Vessel Disease: The Rotterdam Scan Study. Brain. 2006;129:182–188. doi: 10.1093/brain/awh688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh688</ArticleId><ArticleId IdType="pubmed">16317022</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell P., Wang J.J., Wong T.Y., Smith W., Klein R., Leeder S.R. Retinal Microvascular Signs and Risk of Stroke and Stroke Mortality. Neurology. 2005;65:1005–1009. doi: 10.1212/01.wnl.0000179177.15900.ca.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000179177.15900.ca</ArticleId><ArticleId IdType="pubmed">16217050</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh T.C., Kuo C.T., Chou Y.B. Retinal Microvascular Changes in Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review, Meta-Analysis, and Meta-Regression. Front. Aging Neurosci. 2022;14:860759. doi: 10.3389/fnagi.2022.860759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.860759</ArticleId><ArticleId IdType="pmc">PMC9096234</ArticleId><ArticleId IdType="pubmed">35572135</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M., Strand K., Zhang J., Totillo M., Signorile J.F., Galvin J.E., Wang J., Jiang H. Retinal Vessel Density Correlates with Cognitive Function in Older Adults. Exp. Gerontol. 2021;152:111433. doi: 10.1016/j.exger.2021.111433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2021.111433</ArticleId><ArticleId IdType="pmc">PMC8521640</ArticleId><ArticleId IdType="pubmed">34091000</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliani G., Sborgia G., Niro A., Castellana F., Lampignano L., Puzo P., Pascale A., Pastore V., Buonamassa R., Galati R., et al. Correlation between Retinal Vessel Rarefaction and Psychometric Measures in an Older Southern Italian Population. Front. Aging Neurosci. 2022;14:999796. doi: 10.3389/fnagi.2022.999796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.999796</ArticleId><ArticleId IdType="pmc">PMC9541429</ArticleId><ArticleId IdType="pubmed">36212041</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Wei Q., Wu X., Cao S., Chen C., Zhang J., Yan Y., Geng Z., Tian Y., Wang K. The Vessel Density of the Superficial Retinal Capillary Plexus as a New Biomarker in Cerebral Small Vessel Disease: An Optical Coherence Tomography Angiography Study. Neurol. Sci. 2021;42:3615–3624. doi: 10.1007/s10072-021-05038-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05038-z</ArticleId><ArticleId IdType="pubmed">33432462</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.S., Zhou N., Knoll B.M., Samra S., Ward M.R., Weintraub S., Fawzi A.A. Parafoveal Vessel Loss and Correlation between Peripapillary Vessel Density and Cognitive Performance in Amnestic Mild Cognitive Impairment and Early Alzheimer’s Disease on Optical Coherence Tomography Angiography. PLoS ONE. 2019;14:e0214685. doi: 10.1371/journal.pone.0214685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0214685</ArticleId><ArticleId IdType="pmc">PMC6445433</ArticleId><ArticleId IdType="pubmed">30939178</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulut M., Kurtuluş F., Gözkaya O., Erol M.K., Cengiz A., Akldan M., Yaman A. Evaluation of Optical Coherence Tomography Angiographic Findings in Alzheimer’s Type Dementia. Br. J. Ophthalmol. 2018;102:233–237. doi: 10.1136/bjophthalmol-2017-310476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2017-310476</ArticleId><ArticleId IdType="pubmed">28600299</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng S.Y., Wu I.W., Sun C.C., Lee C.C., Liu C.F., Lin Y.Z., Yeung L. Investigation of Possible Correlation Between Retinal Neurovascular Biomarkers and Early Cognitive Impairment in Patients With Chronic Kidney Disease. Transl. Vis. Sci. Technol. 2021;10:9. doi: 10.1167/tvst.10.14.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/tvst.10.14.9</ArticleId><ArticleId IdType="pmc">PMC8684295</ArticleId><ArticleId IdType="pubmed">34902002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Kwapong W.R., Tao W., Cao L., Ye C., Liu J., Zhang S., Wu B. Association of Retinal Thickness and Microvasculature with Cognitive Performance and Brain Volumes in Elderly Adults. Front. Aging Neurosci. 2022;14:1010548. doi: 10.3389/fnagi.2022.1010548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1010548</ArticleId><ArticleId IdType="pmc">PMC9709407</ArticleId><ArticleId IdType="pubmed">36466601</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul F., Erdfelder E., Lang A.-G., Buchner A. G*Power 3: A Flexible Statistical Power Analysis Program for the Social, Behavioral, and Biomedical Sciences. Behav. Res. Methods. 2007;39:175–191. doi: 10.3758/BF03193146.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/BF03193146</ArticleId><ArticleId IdType="pubmed">17695343</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitan R.M.M. Validity of the Trail Making Test as an Indicator of Organic Brain Damage. Percept. Motos Ski. 1958;8:271–276. doi: 10.2466/pms.1958.8.3.271.</Citation><ArticleIdList><ArticleId IdType="doi">10.2466/pms.1958.8.3.271</ArticleId></ArticleIdList></Reference><Reference><Citation>Lezak M.D., Howieson D.B., Bigler E.D., Tranel D. In: Neuropsychological Assessment. 5th ed. Press O.U., editor. Oxford University Press; New York, NY, USA: 2012.</Citation></Reference><Reference><Citation>Wechsler D. Wais III. Escala de Inteligencia de Wechsler para Adultos. Manual de Aplicación. TEA Ediciones. Departamento I+D.; Barcelona, Spain: 2001.</Citation></Reference><Reference><Citation>Peña-Casanova J., Quiñones-Úbeda S., Gramunt-Fombuena N., Quintana-Aparicio M., Aguilar M., Badenes D., Cerulla N., Molinuevo J.L., Ruiz E., Robles A., et al. Spanish Multicenter Normative Studies (NEURONORMA Project): Norms for Verbal Fluency Tests. Arch. Clin. Neuropsychol. 2009;24:395–411. doi: 10.1093/arclin/acp042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acp042</ArticleId><ArticleId IdType="pubmed">19648583</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden C.J. In: Test de Colores y Palabras (Stroop) TEA Ediciones, editor. TEA Ediciones; Madrid, Spain: 2005.</Citation></Reference><Reference><Citation>Cysique L.A., Łojek E., Cheung T.C.K., Cullen B., Egbert A.R., Evans J., Garolera M., Gawron N., Gouse H., Hansen K., et al. Assessment of Neurocognitive Functions, Olfaction, Taste, Mental, and Psychosocial Health in COVID-19 in Adults: Recommendations for Harmonization of Research and Implications for Clinical Practice. J. Int. Neuropsychol. Soc. 2021;28:642–660. doi: 10.1017/S1355617721000862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617721000862</ArticleId><ArticleId IdType="pmc">PMC8825876</ArticleId><ArticleId IdType="pubmed">34365990</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakani K., Ratto M., Sandford-James A., Antonova E., Kumari V. COVID-19 and Cognitive Function: Evidence for Increased Processing Speed Variability in COVID-19 Survivors and Multifaceted Impairment with Long-COVID Symptoms. Eur. Psychiatry. 2023;66:e43. doi: 10.1192/j.eurpsy.2023.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/j.eurpsy.2023.25</ArticleId><ArticleId IdType="pmc">PMC10305372</ArticleId><ArticleId IdType="pubmed">37170616</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J.H., Lin J.J., Twumasi A., Goswami R., Carnavali F., Stone K., Rivera-mindt M., Kale M.S., Naasan G., Festa J.R., et al. Greater Executive Dysfunction in Patients Post-COVID-19 Compared to Those Not Infected. Brain Behav. Immun. 2023;114:111–117. doi: 10.1016/j.bbi.2023.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.08.014</ArticleId><ArticleId IdType="pubmed">37586567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojeda N., del Pino R., Ibarretxe-Bilbao N., Schretlen D.J., Peña J. [Montreal Cognitive Assessment Test: Normalization and Standardization for Spanish Population] Rev. Neurol. 2016;63:488–496. doi: 10.33588/rn.6311.2016241.</Citation><ArticleIdList><ArticleId IdType="doi">10.33588/rn.6311.2016241</ArticleId><ArticleId IdType="pubmed">27874165</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., Bédirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool for Mild Cognitive Impairment. J. Am. Geriatr. Soc. 2005;53:695–699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Gates T.M., Cysique L.A. The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review. CNS Drugs. 2016;30:53–69. doi: 10.1007/s40263-015-0302-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-015-0302-7</ArticleId><ArticleId IdType="pmc">PMC4733144</ArticleId><ArticleId IdType="pubmed">26749584</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall J.C., Murthy S., Diaz J., Adhikari N., Angus D.C., Arabi Y.M., Baillie K., Bauer M., Berry S., Blackwood B., et al. A Minimal Common Outcome Measure Set for COVID-19 Clinical Research. Lancet Infect. Dis. 2020;20:e192–e197. doi: 10.1016/S1473-3099(20)30483-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Haagmans B.L. SARS-CoV-2 Pathogenesis. Nat. Rev. Microbiol. 2022;20:270–284. doi: 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial Cell Infection and Endotheliitis in COVID-19. Lancet. 2020;395:1417–1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Ismail M.Y., Diamond A., Kapoor S., Arafah Y., Nayak L. The Hypercoagulable State in COVID-19: Incidence, Pathophysiology, and Management. Thromb. Res. 2020;194:101–115. doi: 10.1016/j.thromres.2020.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.06.029</ArticleId><ArticleId IdType="pmc">PMC7305763</ArticleId><ArticleId IdType="pubmed">32788101</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose R.J., Manuel A. COVID-19 Cytokine Storm: The Interplay between Inflammation and Coagulation. Lancet Respir. Med. 2020;8:e46–e47. doi: 10.1016/S2213-2600(20)30216-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30216-2</ArticleId><ArticleId IdType="pmc">PMC7185942</ArticleId><ArticleId IdType="pubmed">32353251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Sahu S.K., Cano M., Kuppuswamy V., Bajwa J., McPhatter J., Pine A., Meizlish M.L., Goshua G., Chang C.H., et al. Increased Complement Activation Is a Distinctive Feature of Severe SARS-CoV-2 Infection. Sci. Immunol. 2021;6:eabh2259. doi: 10.1126/sciimmunol.abh2259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh2259</ArticleId><ArticleId IdType="pmc">PMC8158979</ArticleId><ArticleId IdType="pubmed">34446527</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated With Post-COVID-19 Condition A Systematic Review and Meta-Analysis. JAMA Intern. Med. 2023;183:566–580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C., Zurbuchen Y., Taeschler P., Ballouz T., Menges D., Hasler S., Adamo S., Raeber M.E., Bächli E., Rudiger A., et al. Immunoglobulin Signature Predicts Risk of Post-Acute COVID-19 Syndrome. Nat. Commun. 2022;13:446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., et al. Long Covid Outcomes at One Year after Mild SARS-CoV-2 Infection: Nationwide Cohort Study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Taeschler P., Cervia C., Zurbuchen Y., Hasler S., Pou C., Tan Z., Adamo S., Raeber M.E., Bächli E., Rudiger A., et al. Autoantibodies in COVID-19 Correlate with Antiviral Humoral Responses and Distinct Immune Signatures. Allergy Eur. J. Allergy Clin. Immunol. 2022;77:2415–2430. doi: 10.1111/all.15302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15302</ArticleId><ArticleId IdType="pmc">PMC9111424</ArticleId><ArticleId IdType="pubmed">35364615</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler C., Brüningk S.C., Hoch T., Fan B., Muzio G., Thompson R.C., Ceglarek L., Meledin R., Westermann P., Emmenegger M., et al. Persistent Complement Dysregulation with Signs of Thromboinflammation in Active Long Covid. Science. 2024;383:eadg7942. doi: 10.1126/science.adg7942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adg7942</ArticleId><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Park D.H., Connor K.M., Lambris J.D. The Challenges and Promise of Complement Therapeutics for Ocular Diseases. Front. Immunol. 2019;10:1007. doi: 10.3389/fimmu.2019.01007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01007</ArticleId><ArticleId IdType="pmc">PMC6529562</ArticleId><ArticleId IdType="pubmed">31156618</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson S.L., Krishnan A., Patel D., Khanehzar A., Lad A., Shaughnessy J., Ram S., Callanan D., Kunimoto D., Genead M.A., et al. PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration. Pharmaceuticals. 2024;17:517. doi: 10.3390/ph17040517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph17040517</ArticleId><ArticleId IdType="pmc">PMC11053938</ArticleId><ArticleId IdType="pubmed">38675477</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalakas M.C., Alexopoulos H., Spaeth P.J. Complement in Neurological Disorders and Emerging Complement-Targeted Therapeutics. Nat. Rev. Neurol. 2020;16:601–617. doi: 10.1038/s41582-020-0400-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0400-0</ArticleId><ArticleId IdType="pmc">PMC7528717</ArticleId><ArticleId IdType="pubmed">33005040</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpanini S.M., Torvell M., Morgan B.P. Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System. Front. Immunol. 2019;10:362. doi: 10.3389/fimmu.2019.00362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00362</ArticleId><ArticleId IdType="pmc">PMC6409326</ArticleId><ArticleId IdType="pubmed">30886620</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlick S., Lucio M., Wallukat G., Bartsch A., Skornia A., Hoffmanns J., Szewczykowski C., Schröder T., Raith F., Rogge L., et al. Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue. Int. J. Mol. Sci. 2022;23:13683. doi: 10.3390/ijms232213683.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232213683</ArticleId><ArticleId IdType="pmc">PMC9690863</ArticleId><ArticleId IdType="pubmed">36430175</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary Manifestations of COVID-19. Nat. Med. 2020;26:1017–1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y., Jiang H., Wei Y., Shi Y., Shi C., Wright C.B., Sun X., Vanner E.A., Rodriguez A.D., Lam B.L., et al. Visualization of Focal Thinning of the Ganglion Cell-Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer’s Disease. J. Alzheimer’s Dis. 2018;64:1261–1273. doi: 10.3233/JAD-180070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180070</ArticleId><ArticleId IdType="pubmed">30040712</ArticleId></ArticleIdList></Reference><Reference><Citation>Jindahra P., Petrie A., Plant G.T. Retrograde Trans-Synaptic Retinal Ganglion Cell Loss Identified by Optical Coherence Tomography. Brain. 2009;132:628–634. doi: 10.1093/brain/awp001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp001</ArticleId><ArticleId IdType="pubmed">19224900</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutlu U., Ikram M.K., Roshchupkin G.V., Bonnemaijer P.W.M., Colijn J.M., Vingerling J.R., Niessen W.J., Ikram M.A., Klaver C.C.W., Vernooij M.W. Thinner Retinal Layers Are Associated with Changes in the Visual Pathway: A Population-Based Study. Hum. Brain Mapp. 2018;39:4290–4301. doi: 10.1002/hbm.24246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24246</ArticleId><ArticleId IdType="pmc">PMC6866563</ArticleId><ArticleId IdType="pubmed">29935103</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Tao W., Guo X., Kwapong W.R., Ye C., Wang A., Wu X., Wang Z., Liu M. The Association of Retinal Microvasculature With Gray Matter Changes and Structural Covariance Network: A Voxel-Based Morphometry Study. Investig. Opthalmology Vis. Sci. 2023;64:40. doi: 10.1167/iovs.64.15.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.64.15.40</ArticleId><ArticleId IdType="pmc">PMC10756243</ArticleId><ArticleId IdType="pubmed">38153752</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazzaley A., Nobre A.C. Top-down Modulation: Bridging Selective Attention and Working Memory. Trends Cogn. Sci. 2012;16:129–135. doi: 10.1016/j.tics.2011.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tics.2011.11.014</ArticleId><ArticleId IdType="pmc">PMC3510782</ArticleId><ArticleId IdType="pubmed">22209601</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto N.M., Varma R., Torres M., Wong T.Y., Johnson P.L., Segal-Gidan F., MacK W.J. Retinal Microvascular Abnormalities and Cognitive Function in Latino Adults in Los Angeles. Ophthalmic. Epidemiol. 2012;19:127–136. doi: 10.3109/09286586.2011.615452.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09286586.2011.615452</ArticleId><ArticleId IdType="pmc">PMC3598630</ArticleId><ArticleId IdType="pubmed">22568425</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>